Researchers at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide have discovered a faster,
Continue reading »
Potential lines of attack against prostate cancer
Researchers from The University of East Anglia (UEA) have contributed to the world’s largest study into genes that drive prostate
Continue reading »
Three-fold higher risk of cancer after acute thrombosis in the leg
Patients with the most acute type of thrombosis in the leg — known as an arterial thrombosis — risk developing
Continue reading »
First-in-human clinical trial of new targeted therapy drug reports promising responses for multiple cancers: Significant durable disease control seen in patients with lung and thyroid cancers harboring the RET oncogene
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time,
Continue reading »
‘Killer’ kidney cancers identified by studying their evolution: Scientists have discovered that kidney cancer follows distinct evolutionary paths, enabling them to detect whether a tumor will be aggressive
Scientists have discovered that kidney cancer follows distinct evolutionary paths, enabling them to detect whether a tumour will be aggressive
Continue reading »
New precision cancer model opens doors to personalized cancer treatment
Researchers at the Spanish National Cancer Research Centre (CNIO) have developed an extremely powerful and versatile mouse model that will
Continue reading »
Viagra has the potential to be used as a treatment for rare cancers: PDE5 inhibitors such as Viagra® and Cialis® have been identified as having the potential to be repurposed for use in cancer treatment
The class of drugs currently prescribed to treat male erectile dysfunction has been flagged for its potential to be included
Continue reading »
Better quality of life and cancer patients’ satisfaction with a coordinating nurse
Investing in the continuity of care for lung cancer patients can bring tremendous benefits in terms of patient satisfaction and
Continue reading »
Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer
Alectinib provides longer symptom improvement than crizotinib in ALK-positive non-small-cell lung cancer (NSCLC), according to results from the ALEX trial
Continue reading »
Organoids created from patients’ bladder cancers could guide treatment: Custom 3-D mini-tumors mimic individual patient’s cancer
Columbia University Irving Medical Center (CUIMC) and NewYork-Presbyterian researchers have created patient-specific bladder cancer organoids that mimic many of the
Continue reading »